Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case!
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Add Photo/Video
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Loading...
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Washington DC VA Medical Center, 50 Irving St NW, Washington, DC 20422, USA

Latest report: August 24, 2021 5:08 AM
VJ

Pfizer Vaccine

2 years ago

Booster shot Pfizer received today, no adverse symptoms. Date of shot 23 August 2021, condition mild injection site soreness gone within 24 hours. No other symptoms. | Symptoms: Soreness See Less
897


UJ

Over 350 individuals at the VA have tested positive for COVID-19

3 years ago

54 employees and at least 320 patients have tested positive for coronavirus at the Washington DC VA Medical Center.

Source: nbcwashington.com See Less
897


Related Reports

I got this covid booster, and flu shot at the same time. Zero side effects so far, and I am on day 3 now. I assume by now I am in the clear. The picture says moderna, but he assured me it was the pfizer. See Less
544


Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), 100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed in two vials during annual examination of retention samples. The product lot... See More was distributed nationwide to wholesalers/hospitals in the United States from July 16, 2020 through July 24, 2020. To date, Pfizer has not received reports of any adverse events associated with this issue for this lot.

Risk Statement: Patients receiving the impacted product have a remote probability of experiencing potential adverse events, such as blockage of blood vessels, including decreased blood flow to the brain, heart attack, pulmonary embolus, and tissue necrosis. Hypersensitivity reactions and transmission of infectious disease can also occur.

Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion is a terminally sterilized (TS) product. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a Single Patient Use Glass Fliptop Vial. The NDC, Lot Number, Expiration Date, and Configuration details for Propofol Injectable Emulsion are indicated below.

Product: Configuration/Count Propofol Injectable Emulsion, 100 mL Single Patient Use Glass Fliptop Vial
NDC: Vial: 0409-4699-54 Tray: 0409-4699-24
Lot Number: EA7470
Expiration Date: 01 JUNE 2023
Presentation: 1g/100 mL, Single Patient Use Glass Fliptop Vial
Configuration/Count: Tray of 10 Units

Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process. Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

Wholesalers or hospitals with an existing inventory of the lot, which is being recalled, should discontinue use, stop distribution and quarantine immediately. If you have further distributed the recalled product, please notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.

Company name: Hospira, Inc., a Pfizer Company
Brand name: Hospira
Product recalled: Propofol Injection Emulsion, USP
Reason of the recall: Potential presence of visible particulate
FDA Recall date: August 22, 2022

Source: fda.gov
See Less
303


Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), 100 mL Single Patient Use Glass Fliptop Vial; lot DX9067, to the user level due to a visible particulate observed in a single vial during annual examination of retain... See More samples. The product lot was distributed nationwide to wholesalers/ hospitals/Department of Defense in the United States from June 10, 2020 through June 26, 2020.

The recalled product is:
- Propofol Injectable Emulsion, USP 100 mL Single Patient Use Glass Fliptop Vial, NDC: Vial: 0409-4699-54 Carton: 0409-4699-24, Lot Number: DX9067, Expiration Date Presentation: 01 MAY 2023, Configuration/Count: 1 g/100 mL, Single Patient Use Glass Fliptop Vial Case of 10 Units.

Risk Statement: Patients receiving the impacted product are at risk of experiencing life-threatening adverse clinical effects including but not limited to: blockage of blood vessels, including decreased blood flow to the brain, heart attack, pulmonary embolus, and tissue necrosis. Hypersensitivity reactions and transmission of infectious disease can also occur.

To date, Hospira, Inc. has not received reports of any adverse events associated with this issue for this lot. Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion, USP is a terminally sterilized (TS) product. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a single patient use fliptop vial.

Wholesalers or hospitals with an existing inventory of the lot, which is being recalled, should stop use and distribution and quarantine immediately. If you have further distributed the recalled product, to the wholesale or hospital level/institution, please notify any accounts or additional locations which may have received the recalled product from you. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.

Company name: Hospira Inc, A Pfizer Company
Brand name: Hospira
Product recalled: Propofol Injection Emulsion, USP
Reason of the recall: Potential presence of visible particulate
FDA Recall date: July 13, 2022

Source: fda.gov
See Less
303


Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake (ADI) level.... See More To date, Pfizer is not aware of reports of adverse events that have been assessed to be related to this recall. 

Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets. Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.

These products are indicated for the treatment of hypertension.  Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. The products have a safety profile that has been established over 20 years of marketing authorization and through a robust clinical program. Pfizer believes the benefit/risk profile of the products remains positive based on currently available data. Although long term ingestion of N-nitroso-quinapril may be associated with a potential increased cancer risk in humans, there is no immediate risk to patients taking this medication. Patients currently taking the products should consult with their doctor about alternative treatment options.

The NDC, Lot Number, Expiration Date, and Configuration details for these products are indicated in the tables in the link below and photos of the products can be found below. The product lots were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from November 2019 to March 2022.

- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg
- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg
- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg
- quinapril and hydrochlorothiazide tablets, 20/25 mg
- quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg
- quinapril HCl/hydrochlorothiazide tablets, 20/25 mg

Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

Wholesalers and distributors with an existing inventory of the lots, listed in the table above, should stop use and distribution and quarantine the product immediately.

If you have further distributed the recalled product, please notify any accounts or additional locations which may have received the recalled product from you.

Company name: Pfizer
Brand name: Accuretic, Greenstone Brand
Product recalled: Accuretic™ (quinapril HCl/hydrochlorothiazide); quinapril and hydrochlorothiazide; and quinapril HCl/hydrochlorothiazide tablets
Reason of the recall: Presence of a nitrosamine, N-nitroso-quinapril
FDA Recall date: March 22, 2022

Source: fda.gov
See Less
303


FirstEnergy reported power outages impacting about 5,000 customers in West Virginia on Wednesday morning, Mar 27. The affected areas include Washington and Parkersburg in Wood County due to scheduled maintenance. Additionally, the outage map shows an outage in Pine Grove and surrounding areas in Wetzel County, the... See More cause of this outage is under investigation. Crews are working to safely restore power to the area.

Outage link: outages.firstenergycorp.com
Source: firstenergycorp.com
Published: 2024-03-27
See Less
8


A power outage was reported in Northwest DC on Tuesday afternoon when a tractor-trailer struck a power pole at the intersection of Georgia Avenue and Madison Street NW shortly after noon on March 12, according to officials. According to Pepco's outage map, power has been restored to... See More the area.

Outage link: pepco.com
Source: dailyvoice.com
Published: 2024-03-12
See Less
896


About 2,000 customers were affected by power outages in Washington D.C. and Hyattsville on Saturday night, Mar 2nd. The Northeast part of the District, near NoMA and the H Street Corridor, was specifically impacted. As of 9:30 p.m. on Saturday, about 600 customers were still without service.... See More In Hyattsville, Pepco crews were able to restore service to about 1,800 customers in less than two hours. As of 9:30 p.m., about 150 customers were still without service. Crews were still investigating the cause of the outage late Saturday night.

Outage link: pepco.com
Source: news.yahoo.com
Published: 2024-03-03
See Less
896


DC Water Lifts Boil Water Advisory for all affected customers – Effective 5:00 a.m. January 21, 2024. Water lifted the boil water advisory after tests confirmed that drinking water meets all water quality safety standards.

Source: dcwater.com
Published: 2024-01-21 See Less
896


Recent Interesting Reports

I checked my Master Card and I discover a payement of tubuclub Mong Kok HKG of $ 60,89. I don't know this firm or this amount. See Less


I received a product that I did not order. It's a sugar product, for energy , idk , called VERTI Biorbose
From Humble House , the address on the package was ,
Fullfillment House
Po box 5708
Tampa FL. 33675 - 5708
It cane with a clear... See More wrapping, no instructions, couldn't even read what was on the container See Less
239


I received a package of things (no idea what they are) that I did not order. I am checking PayPal as that is my online payment. See Less
1


Ordered a jacket for $137. and they sent me a basketball jersey instead. The costumer service number in the website always hot busy signal.. emailed then and no emailed back See Less


I received a bottle of subgenix cream extra strength 500mg per bottle and I DID NOT ORDER!! I don't even know what it is!! See Less
3


I received two music dancing ducks tots that I did not order from Return Warehouse, 746 S. Glasgow Ave., Inglewood, CA. 90301 See Less
1.6K


I ordered 3 phones. I got a Led x9 power bank and a water bottle instead.
Contact is nowhere just an address.
Old Bud.Cargo.City.
We don't know where to send it back.
Where can we report it? See Less
153


The product they sent me was like a cheap rubber bra and it was not sized right. No return information to send back and get a refund. Lesson learned !! Do not trust any Facebook advertising 🙄 See Less
2.8K


I got some package I didn't order from California company located in flushing NY for a power factor saver I didn't put for anything so I have no idea how to track if they got my CC numbers 192-01 northern Blvd flushing NY 11358 is the address See Less
1.0K


Last 30 days